The differences between pure and mixed invasive micropapillary breast cancer: the epithelial-mesenchymal transition molecules and prognosis

被引:0
作者
Oz, Ozden [1 ]
Yuzuguldu, Resmiye Irmak [2 ]
Yazici, Ayse [3 ]
Cavdar, Demet Kocatepe [1 ]
Yilmaz, Cengiz [4 ]
Ozturk, Mucteba [5 ]
Duzel, Hilal [6 ]
Gurel, Duygu [7 ]
机构
[1] Univ Hlth Sci, Izmir Bozyaka Training & Res Hosp, Dept Pathol, Izmir, Turkiye
[2] Mugla Training & Res Hosp, Dept Pathol, Mugla, Turkiye
[3] Izmir Katip Celebi Univ, Training & Res Hosp, Fac Med, Dept Pathol, Izmir, Turkiye
[4] Univ Hlth Sci, Izmir Bozyaka Training & Res Hosp, Dept Med Oncol, Izmir, Turkiye
[5] Univ Hlth Sci, Izmir Bozyaka Training & Res Hosp, Dept Gen Surg, Izmir, Turkiye
[6] Dokuz Eylul Univ, Med Fac, Dept Publ Hlth, Izmir, Turkiye
[7] Dokuz Eylul Univ, Med Fac, Dept Pathol, Izmir, Turkiye
关键词
Pure breast micropapillary carcinoma; Epithelial-mesenchymal transition (EMT); Prognostic parameters; Prognosis; CARCINOMA; PROGRESSION; FEATURES; VARIANT;
D O I
10.1007/s10549-024-07384-w
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Invasive micropapillary carcinoma (IMPC) of the breast is known for its high metastatic potential, but the definition of pure and mixed IMPC remains unclear. This retrospective cohort study aims to investigate the prognostic significance of the micropapillary component ratio and the expression of critical molecules of epithelial-mesenchymal transition (EMT), including E-cadherin (E-cad), N-cadherin (N-cad), CD44s, and beta-catenin (beta-cat), in distinguishing between pure and mixed IMPCs. Methods We analyzed 100 cases of locally advanced IMPC between 2000 and 2018 and excluded patients who received neoadjuvant chemotherapy. Pure IMPC was defined as having a micropapillary component of over 90%. A comprehensive recording of prognostic parameters was conducted. The IMPC areas were analyzed using the immunohistochemical (IHC) staining method on the microarray set for pure and mixed IMPC patients. Pearson's chi-square, Fisher's exact tests, Kaplan-Meier analysis, and Cox proportional hazards analysis were employed. Results The comparative survival analysis of the entire group, based on overall survival (OS) and disease-free survival (DFS), revealed no significant difference between the pure and mixed groups (P = 0.480, HR = 1.474 [0.502-4.325] and P = 0.390, HR = 1.587 [0.550-4.640], respectively). However, in the pure IMPC group, certain factors were found to be associated with a higher risk of short survival. These factors included skin involvement (P = 0.050), pT3&4 category (P = 0.006), a ratio of intraductal component (> 5%) (P = 0.032), and high-level expression of N-cad (P = 0.020). Notably, none of the risk factors identified for short OS in pure IMPC cases were observed as significant risks in mixed cases and vice versa. Furthermore, N-cad was identified as a poor prognostic marker for OS in pure IMPCs (P = 0.002). Conclusion The selection of a 90% ratio for classifying pure IMPCs revealed significant differences in certain molecular and prognostic parameters between pure and mixed groups. Notably, the involvement of N-cadherin in the epithelial-mesenchymal transition (EMT) process provided crucial insights for predicting OS and DFS while also distinguishing between the two groups. These findings strongly support the notion that the pure IMPC subgroup represents a distinct entity characterized by unique molecular characteristics and behavioral patterns.
引用
收藏
页码:41 / 55
页数:15
相关论文
共 50 条
[31]   Epithelial-Mesenchymal Transition (EMT) and Prostate Cancer [J].
Odero-Marah, Valerie ;
Hawsawi, Ohuod ;
Henderson, Veronica ;
Sweeney, Janae .
CELL & MOLECULAR BIOLOGY OF PROSTATE CANCER: UPDATES, INSIGHTS AND NEW FRONTIERS, 2018, 1095 :101-110
[32]   CD146 Expression Correlates with Epithelial-Mesenchymal Transition Markers and a Poor Prognosis in Gastric Cancer [J].
Liu, Wen-Fang ;
Ji, Shu-Rong ;
Sun, Jian-Jun ;
Zhang, Yi ;
Liu, Zhong-Yan ;
Liang, Ai-Bin ;
Zeng, Hua-Zong .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2012, 13 (05) :6399-6406
[33]   Prognostic value of epithelial-mesenchymal transition related genes: SLUG and QKI in breast cancer patients [J].
Gu, Siwen ;
Chu, Chengyu ;
Chen, Wanna ;
Ren, Hong ;
Cao, Yun ;
Li, Xiaoyan ;
He, Jing ;
Wang, Yiwei ;
Jin, Yiting ;
Liu, Xiuping ;
Zou, Qiang .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2019, 12 (06) :2009-+
[34]   The Effect of Sevoflurane on the Proliferation, Epithelial-Mesenchymal Transition (EMT) and Apoptosis in Human Breast Cancer Cells [J].
Wang, Nan ;
Wang, Mingyu .
JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2022, 36 (03) :583-592
[35]   Oct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patients [J].
Wang, Dan ;
Lu, Ping ;
Zhang, Hao ;
Luo, Minna ;
Zhang, Xin ;
Wei, Xiaofei ;
Gao, Jiyue ;
Zhao, Zuowei ;
Liu, Caigang .
ONCOTARGET, 2014, 5 (21) :10803-10815
[36]   Peroxiredoxin 5 promotes the epithelial-mesenchymal transition in colon cancer [J].
Ahn, Hye-Mi ;
Yoo, Jin-Woo ;
Lee, Seunghoon ;
Lee, Hong Jun ;
Lee, Hyun-Shik ;
Lee, Dong-Seok .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 487 (03) :580-586
[37]   The crosstalk between metabolic reprogramming and epithelial-mesenchymal transition and their synergistic roles in distant metastasis in breast cancer [J].
Yu, Liyan ;
Chen, Yongni ;
Chen, Yingyu ;
Luo, Kangwei .
MEDICINE, 2024, 103 (24) :e38462
[38]   Epithelial-Mesenchymal Transition Markers in Breast Cancer and Pathological Responseafter Neoadjuvant Chemotherapy [J].
Elzamly, Shaimaa ;
Badri, Nabeel ;
Padilla, Osvaldo ;
Dwivedi, Alok Kumar ;
Alvarado, Luis A. ;
Hamilton, Matthew ;
Diab, Nabih ;
Rock, Crosby ;
Elfar, Ahmed ;
Teleb, Marwa ;
Sanchez, Luis ;
Nahleh, Zeina .
BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2018, 12
[39]   2-Hydroxycinnamaldehyde inhibits the epithelial-mesenchymal transition in breast cancer cells [J].
Ismail, Ismail Ahmed ;
Kang, Hye Sook ;
Lee, Heon-Jin ;
Chang, Hyeyoun ;
Yun, Jieun ;
Lee, Chang Woo ;
Kim, Nam Hee ;
Kim, Hyun Sil ;
Yook, Jong In ;
Hong, Su-Hyung ;
Kwon, Byoung-Mog .
BREAST CANCER RESEARCH AND TREATMENT, 2013, 137 (03) :697-708
[40]   Twist expression associated with the epithelial-mesenchymal transition in gastric cancer [J].
Liu, Ai-ning ;
Zhu, Zhi-Hua ;
Chang, Shu-jian ;
Hang, Xiao-sheng .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2012, 367 (1-2) :195-203